Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$221.47 - $242.41 $18,824 - $20,604
-85 Closed
0 $0
Q1 2024

Apr 15, 2024

SELL
$233.45 - $247.73 $4,669 - $4,954
-20 Reduced 19.05%
85 $21 Million
Q4 2023

Jan 30, 2024

SELL
$232.24 - $267.23 $5,109 - $5,879
-22 Reduced 17.32%
105 $25.6 Million
Q1 2023

Dec 18, 2023

BUY
$229.71 - $259.35 $6,202 - $7,002
27 Added 27.0%
127 $31.4 Million
Q4 2022

Dec 18, 2023

BUY
$218.29 - $256.91 $21,829 - $25,691
100 New
100 $25.4 Million
Q3 2022

Dec 18, 2023

SELL
$51.03 - $264.23 $3,521 - $18,231
-69 Reduced 40.83%
100 $22.3 Million
Q1 2022

Dec 18, 2023

BUY
$243.64 - $270.48 $10,232 - $11,360
42 Added 33.07%
169 $45 Million
Q4 2021

Dec 19, 2023

BUY
$230.08 - $250.94 $12,424 - $13,550
54 Added 46.96%
169 $42.5 Million
Q2 2021

Dec 19, 2023

BUY
$232.65 - $254.58 $16,052 - $17,566
69 Added 150.0%
115 $28 Million
Q2 2020

Dec 19, 2023

SELL
$219.9 - $263.41 $17,811 - $21,336
-81 Reduced 63.78%
46 $11 Million
Q1 2020

Dec 20, 2023

SELL
$195.69 - $279.01 $5,087 - $7,254
-26 Reduced 36.11%
46 $10.6 Million
Q4 2019

Dec 21, 2023

SELL
$236.45 - $266.82 $236 - $266
-1 Reduced 1.37%
72 $19.6 Million
Q3 2019

Dec 21, 2023

BUY
$230.58 - $256.08 $230 - $256
1 Added 1.39%
73 $18.5 Million
Q3 2018

Dec 20, 2023

SELL
$233.07 - $256.0 $12,818 - $14,080
-55 Reduced 43.31%
72 $18.8 Million
Q1 2018

Dec 21, 2023

BUY
$205.46 - $240.27 $1,643 - $1,922
8 Added 12.5%
72 $15.6 Million
Q4 2016

Dec 21, 2023

SELL
N/A
-63
64 $10.6 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track West Paces Advisors Inc. Portfolio

Follow West Paces Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.